Endoscopic management of early esophageal cancer in patients with concomitant cirrhosis  

作　　者：Linlin Zhu Zhenming Zhang 

机构地区：[1]General Practice Ward/International Medical Center Ward,General Practice Medical Center,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,China [2]Department of Endoscopy Center,Sichuan Clinical Research Center for Cancer,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,Affiliated Cancer Hospital of University of Electronic Science and Technology of China,Chengdu,Sichuan 610041,China

出　　处：《Chinese Medical Journal》2024年第24期3142-3144,共3页中华医学杂志(英文版)

基　　金：supported by Sichuan Province Medical Young Innovative Research Project Program(No.Q23041).

摘　　要：To the Editor:Based on a recent study examining the burden of digestive diseases in China and its provinces from 1990 to 2019,esophageal cancer ranks as the third leading cause of death among neoplastic digestive diseases,while cirrhosis has the highest incidence among non-neoplastic digestive diseases.[1]Recent advancements in endoscopic techniques have significantly enhanced the ability to diagnose and treat early esophageal cancer(EEC).However,managing EEC in cirrhotic patients presents a complex challenge due to the unique pathophysiological changes associated with portal hypertension and abnormal liver function resulting from liver cirrhosis.Endoscopic treatment is complicated by the need to avoid or manage massive hemorrhage from injured varices and to overcome the submucosal fibrosis caused by previous preventive modalities.

关 键 词：ESOPHAGEAL CIRRHOSIS OVERCOME 

分 类 号：R57[医药卫生—消化系统]